Spots Global Cancer Trial Database for adult diffuse astrocytoma

Every month we try and update this database with for adult diffuse astrocytoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Everolimus in Treating Patients With Recurrent Low-Grade Glioma	NCT00823459	Adult Diffuse A... Adult Mixed Gli... Adult Oligodend... Adult Subependy... Recurrent Adult...	Everolimus Archival Tissue...	18 Years -	University of California, San Francisco
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors	NCT00499798	Brain and Centr... Chemotherapeuti... Infertility		18 Years - 60 Years	Wake Forest University Health Sciences
Everolimus in Treating Patients With Recurrent Low-Grade Glioma	NCT00823459	Adult Diffuse A... Adult Mixed Gli... Adult Oligodend... Adult Subependy... Recurrent Adult...	Everolimus Archival Tissue...	18 Years -	University of California, San Francisco
Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma	NCT01103375	Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Recurrent Adult...	erlotinib hydro... isotretinoin laboratory biom... protein express...	18 Years -	Wake Forest University Health Sciences
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors	NCT00002647	Brain and Centr... Metastatic Canc...	verteporfin conventional su...	3 Years - 70 Years	National Cancer Institute (NCI)
Bevacizumab in Recurrent Grade II and III Glioma	NCT01164189	Central Nervous...	Bevacizumab Temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Everolimus in Treating Patients With Recurrent Low-Grade Glioma	NCT00823459	Adult Diffuse A... Adult Mixed Gli... Adult Oligodend... Adult Subependy... Recurrent Adult...	Everolimus Archival Tissue...	18 Years -	University of California, San Francisco
Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma	NCT00401024	Brain and Centr...	imatinib mesyla... pharmacological... conventional su...	18 Years - 120 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor	NCT00069940	Brain and Centr... Gastrointestina... Sarcoma	sargramostim telomerase: 540...	2 Years -	Dana-Farber Cancer Institute
Melphalan With BBBD in Treating Patients With Brain Malignancies	NCT00253721	Brain and Centr... Lymphoma Metastatic Canc...	Melphalan	18 Years - 120 Years	OHSU Knight Cancer Institute
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas	NCT02175745	Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Childhood High-... Childhood High-... Childhood Low-g... Childhood Low-g... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child...	18F-fluoro-dihy... Positron emissi... Computed tomogr... Magnetic resona...	16 Years -	Stanford University
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors	NCT00541138	Brain and Centr... Metastatic Canc... Unspecified Adu...	carboplatin tamoxifen citra... topotecan hydro... pharmacological...	18 Years -	City of Hope Medical Center
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors	NCT00002608	Adrenocortical ... Brain and Centr... Head and Neck C... Liver Cancer Malignant Mesot... Pheochromocytom... Sarcoma	cisplatin doxorubicin hyd... tamoxifen citra... conventional su... radiation thera...	- 65 Years	National Cancer Institute (NCI)
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases	NCT02967380	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineal Gl... Adult Pineoblas... Adult Primary M... Adult Supratent... Malignant Adult... Metastatic Mali... Multiple Sclero... Recurrent Adult...	Dynamic Contras... Gadobenate Dime... Gadobutrol Gadopentetate D...	18 Years -	University of Southern California
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas	NCT00083096	Brain and Centr...	lonafarnib temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Observation or Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Low-Grade Glioma	NCT00003375	Brain and Centr...	lomustine procarbazine hy... vincristine sul... radiation thera...	18 Years - 120 Years	Radiation Therapy Oncology Group
Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma	NCT00999622	Brain and Centr... Infection	laboratory biom... questionnaire a...	18 Years -	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma	NCT01635283	Adult Diffuse A... Adult Mixed Gli... Adult Oligodend... Recurrent Adult... Adult Oligoastr...	tumor lysate-pu... laboratory biom...	18 Years -	Jonsson Comprehensive Cancer Center
Bevacizumab in Recurrent Grade II and III Glioma	NCT01164189	Central Nervous...	Bevacizumab Temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors	NCT00110032	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Central N... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Grade III... Adult Medullobl... Adult Meningeal... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Pilocytic... Adult Pineoblas... Adult Pineocyto... Adult Subependy... Adult Supratent... Meningeal Melan...	EF5 conventional su... positron emissi... fluorine F 18 E... pharmacological...	18 Years -	National Cancer Institute (NCI)
Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas	NCT01024907	Adult Brain Tum... Adult Brain Ste... Adult Diffuse A... Adult Ependymom... Adult Grade II ... Adult Melanocyt... Adult Meningeal... Adult Mixed Gli... Adult Oligodend... Adult Pineal Gl... Adult Pineocyto... Recurrent Adult...	proton beam rad... quality-of-life... questionnaire a...	18 Years -	Abramson Cancer Center at Penn Medicine
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma	NCT01119599	Acoustic Schwan... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Papillary... Adult Pilocytic... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Primary M... Adult Subependy... Adult Subependy... Adult Supratent... Malignant Adult...	3-Dimensional C... Gamma-Secretase... Intensity-Modul... Laboratory Biom... Pharmacological... Temozolomide Therapeutic Con...	19 Years -	National Cancer Institute (NCI)
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma	NCT00112736	Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Recurrent Adult...	erlotinib temsirolimus therapeutic con... laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors	NCT00967200	Central Nervous...	laboratory biom... pharmacogenomic...	18 Years - 120 Years	University Hospital, Montpellier
Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma	NCT00999622	Brain and Centr... Infection	laboratory biom... questionnaire a...	18 Years -	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sunitinib in Treating Patients With Recurrent Malignant Gliomas	NCT00499473	Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Adult Pineal Gl...	sunitinib malat... pharmacological...	18 Years -	National Cancer Institute (NCI)
Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma	NCT00430079	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Pilocytic... Adult Pineal Gl... Adult Subependy...	etanidazole conventional su... pharmacological... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma	NCT00004024	Brain and Centr...	aldesleukin autologous tumo... muromonab-CD3 sargramostim therapeutic aut... surgical proced... radiation thera...	18 Years -	Barbara Ann Karmanos Cancer Institute
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma	NCT00498927	Brain and Centr...	temozolomide protein express... reverse transcr... diagnostic labo... immunoenzyme te...	18 Years - 120 Years	Memorial Sloan Kettering Cancer Center
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma	NCT01051557	Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Recurrent Adult...	Laboratory Biom... Perifosine Temsirolimus Therapeutic Con...	18 Years -	National Cancer Institute (NCI)
Study of Blood and Cheek Cell Samples From Patients With Glioma	NCT01009307	Brain and Centr...	polymorphism an... laboratory biom... medical chart r...	18 Years - 120 Years	University of California, San Francisco
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders	NCT00255671	Brain and Centr... Metastatic Canc... Radiation Toxic...	Questionnaire	18 Years -	Case Comprehensive Cancer Center
Temozolomide and Radiation Therapy in Treating Patients With Gliomas	NCT00114140	Brain and Centr...	Temozolomide Radiation thera...	18 Years -	Radiation Therapy Oncology Group
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases	NCT02967380	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineal Gl... Adult Pineoblas... Adult Primary M... Adult Supratent... Malignant Adult... Metastatic Mali... Multiple Sclero... Recurrent Adult...	Dynamic Contras... Gadobenate Dime... Gadobutrol Gadopentetate D...	18 Years -	University of Southern California
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors	NCT00541138	Brain and Centr... Metastatic Canc... Unspecified Adu...	carboplatin tamoxifen citra... topotecan hydro... pharmacological...	18 Years -	City of Hope Medical Center
Radiation Therapy or Temozolomide in Treating Patients With Gliomas	NCT00182819	Brain and Centr...	temozolomide radiation thera...	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas	NCT02186509	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Recurrent Adult...	Hyperfractionat... Stereotactic ra... Alisertib Quality-of-life...	18 Years -	Thomas Jefferson University
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors	NCT00629889	Brain and Centr... Seizure	levetiracetam pregabalin	18 Years -	Centre Hospitalier Universitaire Vaudois
Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma	NCT00730613	Brain and Centr...	therapeutic aut... gene expression... laboratory biom...	18 Years - 70 Years	City of Hope Medical Center
Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma	NCT01103375	Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Recurrent Adult...	erlotinib hydro... isotretinoin laboratory biom... protein express...	18 Years -	Wake Forest University Health Sciences
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas	NCT00276770	Brain and Centr...	fluorine F 18 f... positron emissi...	18 Years - 120 Years	University of Washington
Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma	NCT00509431	Brain and Centr...	Erlotinib + Sir...	18 Years -	Jonsson Comprehensive Cancer Center
Temozolomide and Radiation Therapy in Treating Patients With Gliomas	NCT00114140	Brain and Centr...	Temozolomide Radiation thera...	18 Years -	Radiation Therapy Oncology Group
Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction	NCT00030498	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Diffuse A... Adult Ependymob... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Pilocytic... Adult Primary H... Adult Subependy... Advanced Adult ... Advanced Malign... Male Breast Can... Recurrent Adeno... Recurrent Adult... Recurrent Adult... Recurrent Anal ... Recurrent Basal... Recurrent Bladd... Recurrent Breas... Recurrent Cervi... Recurrent Colon... Recurrent Esoph... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Malig... Recurrent Metas... Recurrent Midli... Recurrent Mucoe... Recurrent Non-s... Recurrent Ovari... Recurrent Pancr... Recurrent Prost... Recurrent Recta... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage II Esopha... Stage II Pancre... Stage III Esoph... Stage III Pancr... Stage IIIB Non-... Stage IV Adenoi... Stage IV Anal C... Stage IV Basal ... Stage IV Bladde... Stage IV Breast... Stage IV Colon ... Stage IV Esopha... Stage IV Esthes... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Non-sm... Stage IV Ovaria... Stage IV Pancre... Stage IV Prosta... Stage IV Rectal... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc... Stage IVA Cervi... Stage IVB Cervi... Unspecified Adu... Untreated Metas...	erlotinib hydro... laboratory biom...	18 Years -	National Cancer Institute (NCI)
Chemotherapy Followed by Radiation Therapy in Treating Adults With Supratentorial Glioma	NCT00002806	Brain and Centr...	lomustine procarbazine hy... vincristine sul... low-LET photon ...	18 Years -	Alliance for Clinical Trials in Oncology
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00003567	Brain and Centr... Lymphoma Unspecified Adu...	filgrastim sargramostim therapeutic aut... O6-benzylguanin... carmustine temozolomide in vitro-treate...	18 Years - 70 Years	Case Comprehensive Cancer Center
Yoga Therapy in Treating Patients With Malignant Brain Tumors	NCT01234805	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade II ... Adult Medullobl... Adult Meningeal... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Supratent... Recurrent Adult...	yoga therapy questionnaire a... quality-of-life...	18 Years -	Wake Forest University Health Sciences
Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma	NCT00003567	Brain and Centr... Lymphoma Unspecified Adu...	filgrastim sargramostim therapeutic aut... O6-benzylguanin... carmustine temozolomide in vitro-treate...	18 Years - 70 Years	Case Comprehensive Cancer Center
Temozolomide in Treating Patients With Progressive Low-Grade Glioma	NCT00003466	Brain and Centr...	temozolomide	4 Years -	Duke University
Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment	NCT00544284	Brain and Centr... Lymphoma Metastatic Canc... Unspecified Adu...	bortezomib temozolomide pharmacological...	18 Years -	City of Hope Medical Center
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors	NCT02194452	Acoustic Schwan... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Medullobl... Adult Meningeal... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Papillary... Adult Pilocytic... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Subependy... Adult Subependy... Adult Supratent... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Supra... Meningeal Melan... Newly Diagnosed... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child...	gallium Ga 68-e... positron emissi... computed tomogr... laboratory biom...	6 Months - 29 Years	University of Iowa
Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors	NCT00541138	Brain and Centr... Metastatic Canc... Unspecified Adu...	carboplatin tamoxifen citra... topotecan hydro... pharmacological...	18 Years -	City of Hope Medical Center
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma	NCT01051557	Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Oligodend... Recurrent Adult...	Laboratory Biom... Perifosine Temsirolimus Therapeutic Con...	18 Years -	National Cancer Institute (NCI)
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer	NCT00492089	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Central N... Adult Choroid P... Adult Diffuse A... Adult Ependymom... Adult Grade II ... Adult Grade III... Adult Malignant... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineocyto... Malignant Neopl... Meningeal Melan... Radiation Toxic... Recurrent Adeno... Recurrent Adult... Recurrent Basal... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Midli... Recurrent Mucoe... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage I Adenoid... Stage I Basal C... Stage I Esthesi... Stage I Inverte... Stage I Lymphoe... Stage I Lymphoe... Stage I Midline... Stage I Mucoepi... Stage I Salivar... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Verruco... Stage I Verruco... Stage III Adeno... Stage III Basal... Stage III Esthe... Stage III Inver... Stage III Lymph... Stage III Midli... Stage III Mucoe... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Adenoi... Stage IV Basal ... Stage IV Esthes... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc...	bevacizumab placebo magnetic resona... quality-of-life...	18 Years -	National Cancer Institute (NCI)
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma	NCT00112736	Adult Anaplasti... Adult Anaplasti... Adult Diffuse A... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Mixed Gli... Adult Pilocytic... Adult Pineal Gl... Adult Subependy... Recurrent Adult...	erlotinib temsirolimus therapeutic con... laboratory biom... pharmacological...	18 Years -	National Cancer Institute (NCI)
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors	NCT00629889	Brain and Centr... Seizure	levetiracetam pregabalin	18 Years -	Centre Hospitalier Universitaire Vaudois
Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor	NCT00069940	Brain and Centr... Gastrointestina... Sarcoma	sargramostim telomerase: 540...	2 Years -	Dana-Farber Cancer Institute
Temozolomide in Treating Patients With Low-Grade Glioma	NCT00313729	CNS Tumor, Adul...	temozolomide	18 Years - 120 Years	University of California, San Francisco
Lonafarnib and Temozolomide in Treating Patients With Recurrent Primary Supratentorial Gliomas	NCT00083096	Brain and Centr...	lonafarnib temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma	NCT00999622	Brain and Centr... Infection	laboratory biom... questionnaire a...	18 Years -	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Positron Emission Tomography Using Fluorothymidine F 18 in Finding Recurrent Disease in Patients With Gliomas	NCT00276770	Brain and Centr...	fluorine F 18 f... positron emissi...	18 Years - 120 Years	University of Washington
Bevacizumab in Recurrent Grade II and III Glioma	NCT01164189	Central Nervous...	Bevacizumab Temozolomide	18 Years -	European Organisation for Research and Treatment of Cancer - EORTC
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer	NCT00492089	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Central N... Adult Choroid P... Adult Diffuse A... Adult Ependymom... Adult Grade II ... Adult Grade III... Adult Malignant... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineocyto... Malignant Neopl... Meningeal Melan... Radiation Toxic... Recurrent Adeno... Recurrent Adult... Recurrent Basal... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Midli... Recurrent Mucoe... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage I Adenoid... Stage I Basal C... Stage I Esthesi... Stage I Inverte... Stage I Lymphoe... Stage I Lymphoe... Stage I Midline... Stage I Mucoepi... Stage I Salivar... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Verruco... Stage I Verruco... Stage III Adeno... Stage III Basal... Stage III Esthe... Stage III Inver... Stage III Lymph... Stage III Midli... Stage III Mucoe... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Adenoi... Stage IV Basal ... Stage IV Esthes... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc...	bevacizumab placebo magnetic resona... quality-of-life...	18 Years -	National Cancer Institute (NCI)
Temozolomide in Treating Patients With Low-Grade Glioma	NCT00313729	CNS Tumor, Adul...	temozolomide	18 Years - 120 Years	University of California, San Francisco

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: